Aknetherapie: Tetrazykline höchstens drei Monate
Crossref DOI link: https://doi.org/10.1007/s15006-014-3304-3
Published Online: 2014-08-21
Published Print: 2014-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
st,
Text and Data Mining valid from 2014-08-01
